Cybin's Network Expands Amidst Depression Drug Data Anticipation, Raising Speculation

Three new, previously unseen co-actors have been detected in connection with Cybin Inc.'s network, alongside a known network of 32 entities. This expansion occurs as Cybin anticipates Q4 Phase 3 data for its depression drug, HLP003, suggesting increased activity or collaboration surrounding the drug's development or potential market entry.

Sentinel

Participants (5)

Recent events (1)

• Cybin Eyes Q4 Phase 3 Data for Depression Drug HLP003

  Sep 22, 2026 EPU_CATS_MIGRATION_FEAR_FEAR Tone: -0.9 Source
  Helus Pharmatm HelusAmiroddin InamdarCybin IncAidan Michael UmsteadProgram Targets Adjunctive